Brief: SyntheticMR Receives FDA 510(k) Clearance For Their Next Generation Solution SyMRI 3D
27/03/2024 10:39
March 27 (Reuters) - SyntheticMR AB (publ) SYNTH.TE :
* SYNTHETICMR RECEIVES FDA 510(K) CLEARANCE FOR THEIR NEXT
GENERATION SOLUTION SYMRI 3D
Source text for Eikon: ID:nPn1s5fhGa
Further company coverage: SYNTH.TE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SyntheticMR AB
See all newsSweden's SyntheticMR Q2 sales rise, loss narrows on cNeuro strength, India growth
Brief: SyntheticMR Q2 Operating Profit SEK -6.5 Million
SyntheticMR Q1 net sales fall 8% on lower OEM sales in Europe, North America
Brief: SyntheticMR Q1 Operating Profit SEK -6.3 Million
Sweden's SyntheticMR Q4 sales rise 42% yr/yr